- Home
- NEN vs PROF Comparison
NEN vs PROF Comparison
Compare NEN & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEN
- PROF
- Stock Information
- Founded
- NEN 1977
- PROF N/A
- Country
- NEN United States
- PROF Canada
- Employees
- NEN N/A
- PROF N/A
- Industry
- NEN Building operators
- PROF Medical/Dental Instruments
- Sector
- NEN Real Estate
- PROF Health Care
- Exchange
- NEN Nasdaq
- PROF Nasdaq
- Market Cap
- NEN 248.2M
- PROF 238.5M
- IPO Year
- NEN N/A
- PROF N/A
- Fundamental
- Price
- NEN $80.00
- PROF $7.92
- Analyst Decision
- NEN
- PROF Strong Buy
- Analyst Count
- NEN 0
- PROF 2
- Target Price
- NEN N/A
- PROF $11.40
- AVG Volume (30 Days)
- NEN 369.0
- PROF 72.5K
- Earning Date
- NEN 01-01-0001
- PROF 10-31-2024
- Dividend Yield
- NEN 2.00%
- PROF N/A
- EPS Growth
- NEN 71.00
- PROF N/A
- EPS
- NEN 3.40
- PROF N/A
- Revenue
- NEN $79,924,036.00
- PROF $7,880,000.00
- Revenue This Year
- NEN N/A
- PROF $56.87
- Revenue Next Year
- NEN N/A
- PROF $161.94
- P/E Ratio
- NEN $23.51
- PROF N/A
- Revenue Growth
- NEN 12.08
- PROF 16.67
- 52 Week Low
- NEN $64.00
- PROF $7.11
- 52 Week High
- NEN $83.00
- PROF $11.69
- Technical
- Relative Strength Index (RSI)
- NEN 45.23
- PROF 44.63
- Support Level
- NEN $79.00
- PROF $7.86
- Resistance Level
- NEN $81.00
- PROF $8.48
- Average True Range (ATR)
- NEN 0.36
- PROF 0.33
- MACD
- NEN -0.34
- PROF 0.10
- Stochastic Oscillator
- NEN 25.00
- PROF 46.92
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.